ask="1.19"
ask_size="200"
average_daily_volume="57954"
bid="0.85"
bid_size="300"
book_value="0.69"
change="+0.08"
change_from_200_day_moving_average="-0.39"
change_from_50_day_moving_average="-0.10"
change_from_52_week_high="-6.78"
change_From_52_week_low="0.25"
change_in_percent="+7.34%"
close="1.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-1.09"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.82"
ex_dividend_date="N/A"
float_shares="7095000"
high="1.18"
high_52_weeks="7.95"
last_trade_date="1/4/2017"
last_trade_price="1.17"
last_trade_size="100"
last_trade_time="3:58pm"
low="1.01"
low_52_weeks="0.92"
market_capitalization="19.18M"
moving_average_200_day="1.56"
moving_average_50_day="1.27"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.00"
open="1.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.00%"
percent_change_from_50_day_moving_average="-7.65%"
percent_change_from_52_week_high="-85.28%"
percent_change_from_52_week_low="+27.15%"
previous_close="1.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.57"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.57"
stock_exchange="NGM"
symbol="ORPN"
volume="41735"
weeks_range_52="0.92 - 7.95"
